CoronaCentral

  • Dashboard

  • Trending

  • Epidemiology
    Forecasting & Modelling
    Infection Reports
    Transmission
    Contact Tracing
    Prevalence
    Prevention
    Surveillance
  • Clinical
    Clinical Reports
    Risk Factors
    Long Haul
    Pediatrics
    Medical Specialties
    Recommendations
    Imaging
    Diagnostics
    Healthcare Workers
  • Biology
    Molecular Biology
    Immunology
    Model Systems & Tools
    Non-human
  • Treatment
    Therapeutics
    Drug Targets
    Vaccines
    Clinical Trials
    Medical Devices
  • Psychology
  • Policy
    Health Policy
    Communication
    Inequality
    Education
  • Other Articles
    Reviews
    Meta-analysis
    Comments & Editorials
    CDC Weekly Reports
    Book Chapters
    News
    Non-medical
    Retractions
    Misinformation

  • Mentions
    Drugs
    Genes or Proteins
    Genetic Variation
    Locations
    Medical Specialties
    Prevention Methods
    Risk Factors
    Species
    Symptoms
    Test Types
    Transmission Types
    Vaccine Types
    Viral Lineages

  • FAQs
  • Feedback

Vaccines

Share
Research examining the development of vaccines
Published and Preprint Papers
Filter
Vaccine Types
Title
Altmetric
Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia.

RNA vaccine
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.

adenovirus vaccine
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial.

RNA vaccine
An mRNA Vaccine against SARS-CoV-2 - Preliminary Report.

adenovirus vaccine
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK.

RNA vaccine
BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting.

Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia.

RNA vaccine
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine.

Reports of Anaphylaxis After Receipt of mRNA COVID-19 Vaccines in the US-December 14, 2020-January 18, 2021.

adenovirus vaccine
Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial.

Project funded by the Chan Zuckerberg Biohub and NLM grant LM05652